Searched for
GABAPENTIN
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%The biggest mistake made in currency cycles is to confuse revenue gain with pure earnings gain. A company may report stronger rupee revenue...
- Just the booster pill Indian pharma needsIndian Pharma must look at strengthening its presence in established markets in Latin America, China, Russia, Africa and East Europe. This ...
- Glenmark, Sun Pharma, Zydus recall products in USGlenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, according to the ...
- The painkiller used for just about anythingGabapentin, approved for seizures and postherpetic neuralgia, has become widely used off-label for ailments like fibromyalgia, neuropathy, ...
- Zydus gets USFDA nod for generic medicationZydus Lifesciences announced that it has obtained approval from the USFDA to sell a generic medication for the treatment of postherpetic ne...
- Granules India receives USFDA approval for generic gabapentin tabletsThese tablets are bioequivalent to the reference listed drug product, Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty LLC.
- Glenmark Pharma gets USFDA nod for erectile dysfunction treatmentGlenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets ...
- Buy Hikal, target Rs 218: HDFC SecuritiesBuy Hikal at a price target of Rs 218.
- Lupin gets USFDA nod to market its postherpetic neuralgia drugThe company's tablets are generic version of Pfizer Inc's Neurontin tablets in the same strengths, Lupin said.
- Divi's Labs climbs 3% on minimal impact of USFDA alert on Visakhapatnam unitThe company has initiated necessary measures to address the concerns raised by the US-FDA and is making all efforts to fully meet the compl...
- Divi’s Laboratories nosedives 20%, hits 52-week low on USFDA’s import alertIn a filing to BSE, the drug marker said that the USFDA has exempted the company from making ten drugs.
- Aurobindo, Actavis recall Gabapentin capsulesThe drug is manufactured by Aurobindo Pharma at its Mahabub Nagar facility in Andhra Pradesh.
- Aurobindo Pharma's subsidiary recalls epilepsy drug in USUS-based unit of drug firm Aurobindo Pharma is voluntarily recalling a lot Gabapentin capsules, an anti-epilepsy drug, in the American mark...
- Glenmark recalls three drugs from US marketGlenmark Generics is recalling multiple lots of three of its drugs from the US market due to "odd smell", according to US FDA.
- Take steps to stop use of adulterated drugs in India: Rajinder SacharFormer chief justice of Delhi High Court Rajinder Sachar has demanded that Indian authorities take steps to stop their use in the country.
- Ranbaxy 'systematically violated' good manufacturing practices: WhistleblowerThe Generic drugmaker pleaded guilty to felony charges related to drug safety and will pay $500 mn in civil and criminal fines.
- Ranbaxy to pay $500 mn to US Department of Justice for settlement of felony charges related to drug safetyRanbaxy pleaded guilty to felony charges related to drug safety & will pay $500 mn in fines under settlement agreement with US Department o...
- Ranbaxy recalls 73 million pills from US marketThe company recalled Gabapentin tablets after discovering impurities outside the approved specification limit. Day in pics | Master your tr...
- Sun Pharma to invest $60-70 mn in research opsMumbai-based drug firm Sun Pharma is planning to hive-off its research operations into a separate entity.
Load More
